Equity Analysis

Quarterly Results

    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    3.255251
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    9.67
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.000.000.00
Total Income0.000.000.00
Total Expenditure 0.400.550.37
PBIDT-0.40-0.55-0.37
Interest 0.000.000.00
PBDT-0.40-0.55-0.37
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-0.40-0.55-0.37
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.40-0.55-0.37
EPS (Unit Curr.)-3.94-1.24-0.84
EPS (Adj) (Unit Curr.)-3.94-1.24-0.84
Calculated EPS (Unit Curr.)-0.90-1.24-0.84
Calculated EPS (Adj) (Unit Curr.)-0.90-1.24-0.84
Calculated EPS (Ann.) (Unit Curr.)-3.62-4.97-3.38
Calculated EPS (Adj) (Ann.) (Unit Curr.)-3.62-4.97-3.38
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity4.394.394.39
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-3.94-1.24-0.84